MIRA Stock Catalyst: MIRA Pharmaceuticals Approves Acquisition of SKNY Pharma

May 7, 2025 · 7:28pm ET

The combined enterprise value of the acquisition exceeds $60 million.

Max move

+46.7%

High of day $1.79

Sparker timei

7:28pm ET

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

MIRA Pharmaceuticals, Inc. announced MIRA Pharmaceuticals' Board approves acquisition of SKNY Pharma.

The announcement cited $5 million, and over $60 million.

MIRA Pharmaceuticals, Inc. Common Stock has a free float of 34,944,300 shares and 41,876,100 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time MIRA sparks.

Catch the next MIRA-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.